<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37996650</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2520-8721</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Hormones (Athens, Greece)</Title><ISOAbbreviation>Hormones (Athens)</ISOAbbreviation></Journal><ArticleTitle>A prospective study on endocrine function in patients with long-COVID symptoms.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>67</EndPage><MedlinePgn>59-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s42000-023-00511-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate hormonal status in patients with long-COVID and explore the interrelationship between hormone levels and long-COVID symptoms.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective observational study.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Patients who visited our long-COVID outpatients' clinic due to long-COVID symptoms from February 2021 to December 2022.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Total triiodothyronine, free thyroxine, thyrotropin, thyroglobulin, anti-thyroperoxidase, and antithyroglobulin autoantibodies were measured for thyroid assessment. Other hormones measured were growth hormone, insulin-like growth factor 1 (IGF-1), adrenocorticotropic hormone (ACTH), serum cortisol, dehydroepiandrosterone sulfate (DHEA-S), total testosterone, plasma insulin, and C-peptide. Blood glucose and glycosylated hemoglobin were also measured. To assess adrenal reserve, an ACTH stimulation test was performed. The fatigue assessment scale (FAS) was used to evaluate fatigue severity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty-four adult patients were included. Overall, 40.5% of the patients had at least one endocrine disorder. These included prediabetes (21.4%), low DHEA-S (21.4%), subclinical hypothyroidism (3.6%), non-specific thyroid function abnormality (7.1%), thyroid autoimmunity (7.1%), low testosterone in males (6.6%), and low IGF-1 (3.6%). All patients had normal adrenal reserve. Long-COVID-19 symptoms were present in all patients and the most commonly reported symptom was fatigue (89.3%). The FAS score was higher than normal (&#x2265;&#x2009;22) in 42.8% of patients. There were no associations between patients' symptoms and hormone levels. Diabetic patients reported confusion (p&#x2009;=&#x2009;0.020) and hair loss (p&#x2009;=&#x2009;0.040) more often than non-diabetics.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The evaluation of endocrine function 3&#xa0;months after a positive SARS-CoV2 test revealed only subclinical syndromes. The vast majority of patients reported mainly fatigue, among other symptoms, which were unrelated, however, to endocrine function.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Hellenic Endocrine Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mourelatos</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vrettou</LastName><ForeName>Charikleia S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0002-1067-8849</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care Medicine &amp; Pulmonary Services, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, Athens, Greece. vrettou@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diamantopoulos</LastName><ForeName>Aristidis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassiliou</LastName><ForeName>Alice G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>First Department of Critical Care Medicine &amp; Pulmonary Services, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahaj</LastName><ForeName>Edison</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>First Department of Critical Care Medicine &amp; Pulmonary Services, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelousi</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Endocrinology, First Department of Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratikaki</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biochemical Department, Evangelismos Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsaounou</LastName><ForeName>Paraskevi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>First Department of Critical Care Medicine &amp; Pulmonary Services, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotanidou</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>First Department of Critical Care Medicine &amp; Pulmonary Services, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassiliadi</LastName><ForeName>Dimitra A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimopoulou</LastName><ForeName>Ioanna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>First Department of Critical Care Medicine &amp; Pulmonary Services, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Hormones (Athens)</MedlineTA><NlmUniqueID>101142469</NlmUniqueID><ISSNLinking>1109-3099</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9002-60-2</RegistryNumber><NameOfSubstance UI="D000324">Adrenocorticotropic Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>459AG36T1B</RegistryNumber><NameOfSubstance UI="D003687">Dehydroepiandrosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical><Chemical><RegistryNumber>67763-96-6</RegistryNumber><NameOfSubstance UI="D007334">Insulin-Like Growth Factor I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance UI="D013739">Testosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013963">Thyroid Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-71-5</RegistryNumber><NameOfSubstance UI="D013972">Thyrotropin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000324" MajorTopicYN="N">Adrenocorticotropic Hormone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003687" MajorTopicYN="N">Dehydroepiandrosterone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007334" MajorTopicYN="Y">Insulin-Like Growth Factor I</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013963" MajorTopicYN="N">Thyroid Hormones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013972" MajorTopicYN="N">Thyrotropin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adrenal function</Keyword><Keyword MajorTopicYN="N">Endocrine dysfunction</Keyword><Keyword MajorTopicYN="N">Fatigue assessment</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Thyroid function</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>23</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37996650</ArticleId><ArticleId IdType="doi">10.1007/s42000-023-00511-0</ArticleId><ArticleId IdType="pii">10.1007/s42000-023-00511-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC et al (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22:e102&#x2013;e107. https://doi.org/10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY (2022) Long-term complications of COVID-19. Am J Physiol Cell Physiol 322:C1&#x2013;C11. https://doi.org/10.1152/AJPCELL.00375.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/AJPCELL.00375.2021</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards EM, Raizada MK (2018) ACE2 and pACE2: a pair of aces for pulmonary arterial hypertension treatment? Am J Respir Crit Care Med 198:422&#x2013;423. https://doi.org/10.1164/rccm.201803-0569ED</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201803-0569ED</ArticleId><ArticleId IdType="pubmed">29634285</ArticleId><ArticleId IdType="pmc">6118027</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliadi DA, Vassiliou AG, Ilias I et al (2021) Pituitary&#x2013;adrenal responses and glucocorticoid receptor expression in critically ill patients with covid&#x2010;19. Int J Mol Sci 22. https://doi.org/10.3390/ijms222111473</Citation></Reference><Reference><Citation>Diamantopoulos A, Dimopoulou I, Mourelatos P et al (2022) Endocrine aspects of ICU-hospitalized COVID-19 patients. J Pers Med 2022;12(10). https://doi.org/10.3390/jpm12101703</Citation></Reference><Reference><Citation>Ilias I, Diamantopoulos A, Botoula E et al (2021) COVID-19 and growth hormone/insulin-like growth factor 1: study in critically and non-critically ill patients. Front Endocrinol (Lausanne) 12. https://doi.org/10.3389/fendo.2021.644055</Citation></Reference><Reference><Citation>Ilias I, Diamantopoulos A, Pratikaki M et al (2021) Glycemia, beta-cell function and sensitivity to insulin in mildly to critically ill covid-19 patients. Medicina (Lithuania) 57:1&#x2013;6. https://doi.org/10.3390/medicina57010068</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57010068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilias I, Pratikaki M, Diamantopoulos A et al (2022) Testosterone, free, bioavailable and total, in patients with coVid-19. Minerva Endocrinol 47:111&#x2013;116. https://doi.org/10.23736/S2724-6507.21.03610-1</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S2724-6507.21.03610-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Athanasiou N, Keskinidou C et al (2021) Increased glucocorticoid receptor alpha expression and signaling in critically ill coronavirus disease 2019 patients. Crit Care Med 49:2131&#x2013;2136. https://doi.org/10.1097/CCM.0000000000005097</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005097</ArticleId><ArticleId IdType="pubmed">34034298</ArticleId><ArticleId IdType="pmc">8594506</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliadi DA, Ilias I, Pratikaki M et al (2021) Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection. Endocr Connect 10:646&#x2013;655. https://doi.org/10.1530/EC-21-002911</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-21-002911</ArticleId><ArticleId IdType="pubmed">34010152</ArticleId><ArticleId IdType="pmc">8240704</ArticleId></ArticleIdList></Reference><Reference><Citation>Urhan E, Karaca Z, Unuvar GK et al (2022) Investigation of pituitary functions after acute coronavirus disease 2019. Endocr J 69(6):649&#x2013;658. https://doi.org/10.1507/endocrj.EJ21-0531</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ21-0531</ArticleId><ArticleId IdType="pubmed">34987144</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow MKS, Kwek DSK, Ng AWK et al (2005) Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 63:197&#x2013;202. https://doi.org/10.1111/j.1365-2265.2005.02325.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleare AJ (2003) The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 24:236&#x2013;252. https://doi.org/10.1210/er.2002-0014</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2002-0014</ArticleId><ArticleId IdType="pubmed">12700181</ArticleId></ArticleIdList></Reference><Reference><Citation>Praw SS, Brent GA (2023) Approach to the patient with a suppressed TSH. J Clin Endocrinol Metab 108:472&#x2013;482. https://doi.org/10.1210/clinem/dgac635</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgac635</ArticleId><ArticleId IdType="pubmed">36329632</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappa TA, Vagenakis AG, Alevizaki M (2011) The nonthyroidal illness syndrome in the non-critically ill patient. Eur J Clin Invest 41:212&#x2013;220. https://doi.org/10.1111/j.1365-2362.2010.02395.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2010.02395.x</ArticleId><ArticleId IdType="pubmed">20964678</ArticleId></ArticleIdList></Reference><Reference><Citation>Biondi B, Cappola AR, Cooper DS (2019) Subclinical hypothyroidism: a review. JAMA &#x2013; J Am Med Assoc 322:153&#x2013;160. https://doi.org/10.1001/jama.2019.9052</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.9052</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebye ES, Pearce SH, Krone NP, K&#xe4;mpe O (2021) Adrenal insufficiency. The Lancet 397:613&#x2013;629. https://doi.org/10.1016/S0140-6736(21)00136-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00136-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischli S, Jenni S, Allemann S et al (2008) Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis. Diabetes, Clin Nutr. https://doi.org/10.7892/boris.22082</Citation><ArticleIdList><ArticleId IdType="doi">10.7892/boris.22082</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanson P, Arnoux A, Mavromati M et al (2016) Reference values for IGF-I serum concentrations: comparison of six immunoassays. J Clin Endocrinol Metab 101:3450&#x2013;3458. https://doi.org/10.1210/jc.2016-1257</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2016-1257</ArticleId><ArticleId IdType="pubmed">27167056</ArticleId><ArticleId IdType="pmc">5054194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanauchi M, Yamano S, Kanauchi K, Saito Y (2003) Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-normal blood pressure. J Clin Endocrinol Metab 88:3444&#x2013;3446. https://doi.org/10.1210/jc.2002-021641</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2002-021641</ArticleId><ArticleId IdType="pubmed">12843200</ArticleId></ArticleIdList></Reference><Reference><Citation>Michielsen HJ, De Vries J, Van Heck GL (2003) Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. J Psychosom Res 54:345&#x2013;352. https://doi.org/10.1016/S0022-3999(02)00392-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(02)00392-6</ArticleId><ArticleId IdType="pubmed">12670612</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x391;&#x3bb;&#x3b9;&#x3ba;&#x3ac;&#x3c1;&#x3b7; &#x392;, &#x3a6;&#x3c1;&#x3b1;&#x3b4;&#x3ad;&#x3bb;&#x3bf;&#x3c2; &#x395;, &#x3a3;&#x3b1;&#x3c7;&#x3bb;&#x3ac;&#x3c2; &#x391; et al (2016) Reliability and validity of the Greek version of &#x201c;The Fatigue Assessment Scale 33:2016. http://www.mednet.gr/archives</Citation></Reference><Reference><Citation>Yang JK, Lin SS, Ji XJ, Guo LM (2010) Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 47:193&#x2013;199. https://doi.org/10.1007/s00592-009-0109-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-009-0109-4</ArticleId><ArticleId IdType="pubmed">19333547</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, Ben Nasr M, D&#x2019;Addio F et al (2021) Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab 3:774&#x2013;785. https://doi.org/10.1038/s42255-021-00407-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId><ArticleId IdType="pmc">9931026</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Guo H, Wang G et al (2023) COVID-19 as a trigger for type 1 diabetes. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgad165</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad165</ArticleId><ArticleId IdType="pubmed">38157274</ArticleId><ArticleId IdType="pmc">10795920</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke SA, Phylactou M, Patel B et al (2022) Preserved C-peptide in survivors of COVID-19: post hoc analysis. Diabetes Obes Metab 24:570&#x2013;574. https://doi.org/10.1111/dom.14608</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14608</ArticleId><ArticleId IdType="pubmed">34850532</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal N (2015) Prediabetes diagnosis and treatment: a review. World J Diabetes 6:296. https://doi.org/10.4239/wjd.v6.i2.296</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v6.i2.296</ArticleId><ArticleId IdType="pubmed">25789110</ArticleId><ArticleId IdType="pmc">4360422</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke SA, Phylactou M, Patel B et al (2021) Normal adrenal and thyroid function in patients who survive COVID-19 infection. J Clin Endocrinol Metab 106:2208&#x2013;2220. https://doi.org/10.1210/clinem/dgab349</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab349</ArticleId><ArticleId IdType="pubmed">34008009</ArticleId><ArticleId IdType="pmc">8194556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Tsoi KH, Lee CH et al (2023) A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors. Endocrine. https://doi.org/10.1007/s12020-022-03281-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-022-03281-8</ArticleId><ArticleId IdType="pubmed">37985574</ArticleId><ArticleId IdType="pmc">9810240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N, Honda H, Nakano Y et al (2022) Hormonal trends in patients suffering from long COVID symptoms. Endocr J 69(10):1173&#x2013;1181. https://doi.org/10.1507/endocrj.EJ22-0093</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0093</ArticleId><ArticleId IdType="pubmed">35491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS et al (2021) Long COVID in patients with mild to moderate disease: do thyroid function and autoimmunity play a role? Endocr Pract 27:894&#x2013;902. https://doi.org/10.1016/j.eprac.2021.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2021.06.016</ArticleId><ArticleId IdType="pubmed">34237471</ArticleId><ArticleId IdType="pmc">8257401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroboth PD, Salek FS, Pittenger AL et al (1999) DHEA and DHEA-S: a review. J Clin Pharmacol 39:327&#x2013;348. https://doi.org/10.1177/00912709922007903</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00912709922007903</ArticleId><ArticleId IdType="pubmed">10197292</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O, Merino E, Alfayate R et al (2022) Male pituitary&#x2013;gonadal axis dysfunction in post-acute COVID-19 syndrome&#x2014;prevalence and associated factors: a Mediterranean case series. Clin Endocrinol (Oxf) 96:353&#x2013;362. https://doi.org/10.1111/cen.14537</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14537</ArticleId><ArticleId IdType="pubmed">34160836</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonia A, Pontillo M, Capogrosso P et al (2022) Testosterone in males with COVID-19: a 7-month cohort study. Andrology 10:34&#x2013;41. https://doi.org/10.1111/andr.13097</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.13097</ArticleId><ArticleId IdType="pubmed">34409772</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Maes M (2013) Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics. BMC Med 11. https://doi.org/10.1186/1741-7015-11-205</Citation></Reference><Reference><Citation>Joli J, Buck P, Zipfel S (2022) Stengel A (2022) Post-COVID-19 fatigue: a systematic review. Front Psychiatry 11(13):947973. https://doi.org/10.3389/fpsyt.2022.947973</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.947973</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammer F, Subtil S, Lux P et al (2005) No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: In vivo and in vitro studies. J Clin Endocrinol Metab 90:3600&#x2013;3605. https://doi.org/10.1210/jc.2004-2386</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2004-2386</ArticleId><ArticleId IdType="pubmed">15755854</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>